Atea Pharmaceuticals (NASDAQ: AVIR) grants options and RSUs to director
This story is reported by Stock Titan. Read what other outlets are saying below, then open the original report for full details.
This story is reported by Stock Titan. Read what other outlets are saying below, then open the original report for full details.